Funder: Johnson & Johnson (Janssen)
Due Dates: June 30, 2026: Grant application deadline for the 2026 Implementation Science RFP (IS RRMM BSAB 2026)
Funding Amounts: Up to $275,000 per project; lower-cost projects prioritized; maximum duration 18 months
Summary: Supports implementation science-driven educational initiatives to improve care for relapsed/refractory multiple myeloma patients, with a focus on integrating evidence-based practices in community settings.
Key Information: General research projects are not eligible; only CME/CE-certified education embedded in implementation efforts will be considered.